Flamingo Therapeutics, Inc.
07/07/2025
Acknowledgment of the special report in accordance with article 7:228 of the Belgian Code of Companies and Associations, regarding the continuation of the business activities
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Approval of the continuation of the business activities
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Acknowledgment of the annual report of the Board of Directors regarding the fiscal year ended on 31 December 2024
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Acknowledgment of the report of the statutory auditor
AUDIT-RELATED
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Approval of the annual accounts for the fiscal year ended on 31 December 2024
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Allocation of the results
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Release of liability to the directors and the statutory auditor for the exercise of their mandate during the past fiscal year
AUDIT-RELATED
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Acknowledgment of the special report in accordance with article 7:228 of the Belgian Code of Companies and Associations, regarding the continuation of the business activities
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Approval of the continuation of the business activities
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Acknowledgment of the annual report of the Board of Directors regarding the fiscal year ended on 31 December 2024
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Acknowledgment of the report of the statutory auditor
AUDIT-RELATED
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Approval of the annual accounts for the fiscal year ended on 31 December 2024
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Allocation of the results
CORPORATE GOVERNANCE
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
Flamingo Therapeutics, Inc.
07/07/2025
Release of liability to the directors and the statutory auditor for the exercise of their mandate during the past fiscal year
AUDIT-RELATED
ISSUER
107120.000000
0.000000
FOR
107120.000000
FOR
ProThera Limited
10/21/2025
To receivee and consider the Company's Financial Statements for the year ended 31 December 2023 and the reports of the Directors and Auditors on those Financial Statements
AUDIT-RELATED
ISSUER
152534.000000
0.000000
FOR
152534.000000
FOR
ProThera Limited
10/21/2025
To review the Company's affairs
CORPORATE GOVERNANCE
ISSUER
152534.000000
0.000000
FOR
152534.000000
FOR
ProThera Limited
10/21/2025
To re-appoint the Company statutory auditors to continue in office pursuant to section 383 of the Companies Act 2014
AUDIT-RELATED
ISSUER
152534.000000
0.000000
FOR
152534.000000
FOR
ProThera Limited
10/21/2025
To authorise the directors to approve the remuneration of the statutory auditors for the year ended 31 December 2024
AUDIT-RELATED
ISSUER
152534.000000
0.000000
FOR
152534.000000
FOR
ProThera Limited
10/21/2025
To adopt the Constitution of the Company in the form presented
CORPORATE GOVERNANCE
ISSUER
152534.000000
0.000000
FOR
152534.000000
FOR